Preprint
Hypothesis

This version is not peer-reviewed.

The Continuous Mucosal Liquid Layer: A Unified Hypothesis for Airway-Digestive Immune Surveillance, Mucociliary Transport, and Disease Susceptibility

Submitted:

11 May 2026

Posted:

12 May 2026

You are already at the latest version

Abstract
Background: The mucosal surfaces from the anterior nares to the anal canal are lined by a continuous liquid layer studied extensively in regional isolation — as airway surface liquid in pulmonary physiology, gastric mucus in gastroenterology, and nasal mucus in rhinology — but never conceptualized as a unified physiological system. Framework: This paper proposes that this continuous mucosal liquid layer functions as a "mucosal river" serving three critical roles: physical barrier protection, immune transport of secretory immunoglobulins and antimicrobial peptides, and maintenance of the hydrated microenvironment required for commensal microbial homeostasis. Nasal cilia function as the initial pump generating downstream momentum; pharyngeal and digestive peristalsis maintain flow; pulmonary cilia serve as tributary pumps feeding the main channel against gravity. The adenoid crypts function as immunological canyons — narrow, deep channels that use Venturi-effect flow dynamics and M-cell-mediated antigen transport to actively deliver antigen-laden mucus into immune processing centers. Waldeyer's ring forms a 360-degree antigen trap through which the river cannot pass without immune surveillance, and the first breath represents an immunological ignition event initiating adaptive immunity. Hypotheses: The framework generates testable predictions regarding pepsin as a pathologic passenger ascending the river against flow to cause posterior-predominant sinonasal inflammation, systemic dehydration disrupting the river through mucus hyperconcentration and ciliary compression, cigarette smoke damming the river via acquired CFTR dysfunction, and an antibiotic-dehydration "double hit" synergistically compromising mucosal barrier integrity. Each prediction is paired with a specific experimental design for validation. Conclusion: Understanding the mucosal river as a unified system may reshape approaches to chronic inflammatory diseases of the airway and digestive tract.
Keywords: 
;  ;  ;  ;  ;  ;  ;  

1. Introduction

The mucosal surfaces of the human body — from the anterior nares to the anal canal — are lined by a continuous liquid layer that serves as both a physical barrier and an active transport medium. This layer has been studied extensively in regional isolation: as airway surface liquid in pulmonary physiology, as gastric and intestinal mucus in gastroenterology, and as nasal mucus in rhinology.[1,2,3,4,5] Each regional literature has characterized the local composition, thickness, and function of its segment in considerable detail.
These regional segments, however, are physically continuous. No anatomical discontinuity exists in the mucosal lining from the anterior nares to the anus.[3,4] The liquid layer covering the nasal epithelium flows posteriorly via mucociliary clearance to the nasopharynx, where it merges with pulmonary secretions ascending from the lungs via the mucociliary escalator and with saliva from the oral cavity. Fahy and Dickey (2010) estimated that approximately 1.5 liters per day of nasal mucus and 30 mL per day of pulmonary secretions are swallowed — entering the esophagus, stomach, small intestine, colon, and rectum before elimination.[2]
This paper proposes that this continuous mucosal liquid layer functions as a unified physiological system — a "mucosal river" — serving three critical roles: (1) physical barrier protection against pathogens and environmental antigens, (2) immune transport of secretory immunoglobulins, antimicrobial peptides, cytokines, and immune cells, and (3) maintenance of the hydrated microenvironment required for commensal microbial homeostasis. Disruption of this system — by dehydration, inhaled toxicants, or antibiotic-induced dysbiosis — may underlie chronic inflammatory diseases of the airway and digestive tract, including chronic rhinosinusitis, chronic bronchitis, and inflammatory bowel disease.

2. Anatomy of Continuity

The mucosal liquid layer begins at the anterior nares, where submucosal glands and goblet cells secrete a biphasic fluid consisting of a low-viscosity periciliary layer (PCL) in direct contact with the epithelial surface and an overlying gel layer. Fahy and Dickey (2010) described the gel layer as composed primarily of the mucin MUC5AC, with MUC5B predominating in the submucosal glands.[2] Bustamante-Marin and Ostrowski (2017) characterized ciliary beating at 12–15 Hz, propelling this mucus posteriorly at approximately 1 mm/min toward the nasopharynx.[1]
In the paranasal sinuses, mucus produced by goblet cells and submucosal glands within the sinus cavities is transported through the natural ostia into the nasal cavity by mucociliary clearance, joining the nasal mucus stream.[1] The middle ear mucosa is continuous with the nasopharynx via the eustachian tube, and its secretions drain into the nasopharyngeal confluence. Schilder et al. (2016) described this eustachian tube drainage as a critical component of middle ear homeostasis.[5]
The nasopharynx represents the first major confluence. Nasal mucus from both nasal cavities converges here with mucus draining from the eustachian tubes and with pulmonary secretions that have ascended the tracheobronchial tree via the mucociliary escalator, crossed the larynx at the posterior commissure, and entered the pharynx.[1,2] Saliva — approximately 0.5–1.5 liters per day — adds further volume in the oropharynx.
This combined fluid is swallowed via pharyngeal and esophageal peristalsis into the stomach, where it encounters the gastric mucus layer — a distinct but physically continuous mucus barrier. Johansson et al. (2013) described this gastric layer as composed primarily of MUC5AC and MUC6.[3] From the stomach, the liquid layer continues through the small intestine (where MUC2 becomes the dominant mucin) and colon. Pelaseyed et al. (2014) characterized the colonic mucus as a dense, firmly adherent inner layer and a loose outer layer providing the primary barrier separating commensal bacteria from the epithelium.[4] Gustafsson and Johansson (2022) further detailed how goblet cells maintain intestinal mucus homeostasis through regulated secretion and turnover.[40]
At no point in this tract does an anatomical break in the mucosal lining exist. The regional differences in mucin composition, layer thickness, and cellular architecture are adaptations to local functional requirements, but the physical continuity of the liquid layer is uninterrupted.

3. Hydrodynamics of the Mucosal River: Ciliary Pump-Priming, Peristaltic Pull, and Flow Dynamics

The mucosal liquid layer does not flow passively. It requires an initiating force, and the nasal epithelial cilia provide it. The sinonasal cavity represents the headwaters of the river, with cilia functioning as the initial pump that creates downstream momentum — analogous to a river's source, where once flow is established, gravity and peristaltic forces maintain it downstream.
Bustamante-Marin and Ostrowski (2017) described the coordinated metachronal wave pattern of nasal cilia beating at 10–15 Hz, generating directional flow toward the nasopharynx.[1] This ciliary beat creates a flow velocity of approximately 3–25 mm/min across the nasal mucosal surface. The flow follows defined pathways along the nasal floor, medial to the inferior turbinate, and along the septum, all converging posteriorly toward the nasopharynx.
Once the river reaches the nasopharynx, pharyngeal peristalsis and gravity take over as the driving forces, pulling the river inferiorly through the oropharynx, hypopharynx, and into the esophagus. In the lungs, cilia perform the opposite function — pushing mucus upward against gravity from the distal airways to the glottis, where it joins the main river flowing downward. This is the only segment where ciliary force must overcome gravity, which explains why pulmonary mucociliary clearance is the most vulnerable segment of the river to disruption by smoking, CFTR dysfunction, or primary ciliary dyskinesia.[1,6]
Three motor systems drive the river: nasal cilia are the pump that starts it; pharyngeal and digestive peristalsis are the current that maintains it; pulmonary cilia are the tributary pumps that feed into the main channel against gravity. Disruption of any of these three systems causes the river to slow, pool, or stagnate — creating conditions for bacterial overgrowth, biofilm formation, and chronic inflammation.
A downstream pulling effect operates as a key hydrodynamic principle. In fluid dynamics, a flowing stream creates downstream traction on connected fluid. Pharyngeal peristalsis does not just move food — it creates a downstream traction force on the entire mucosal liquid layer above it, pulling the nasal mucus river posteriorly and inferiorly. Swallowing — which occurs approximately 600 times per day in a normal adult — creates intermittent high-velocity bolus flow that generates a pulsatile pulling force on the upstream river, accelerating mucus clearance from the nasal cavity and nasopharynx with each swallow. Esophageal and intestinal peristalsis continue this pulling force through the gastrointestinal tract.
This pulling effect explains several clinical observations. Nasal congestion worsens when lying flat because gravity no longer assists the pulling effect and pharyngeal peristalsis is reduced during sleep. Swallowing difficulty can worsen sinonasal symptoms because reduced swallowing frequency decreases the pulsatile pulling force. Dehydration worsens sinonasal disease because reduced fluid volume decreases the river's mass and the downstream traction force it generates. Post-nasal drip is perceived when the river slows — mucus always flows posteriorly, but it is only perceived when it thickens from dehydration or pools from reduced pulling force.

4. The Adenoid Canyons: Active Hydrodynamic Antigen Delivery

The adenoid has a deeply fissured, cryptic surface architecture — irregular channels and grooves that dramatically increase surface area. Van Kempen et al. (2000) described this architecture as consisting of deep crypts lined by specialized epithelium.[7] Brandtzaeg (2003) characterized the adenoid as the primary nasopharyngeal lymphoid organ, positioned to intercept inhaled antigens at the airway entrance.[8] These crypts function as immunological canyons — narrow, deep channels that trap and concentrate antigen-laden mucus carried by the river, analogous to slot canyons in a river system where narrow passages trap sediment, concentrate flow, and create unique microenvironments.
Standard descriptions of adenoid immune function imply that antigens contact the surface of the adenoid tissue and are sampled by surface immune cells.[7,8] The mucosal river framework proposes something different: the river actively channels mucus into the deep crypts of the adenoid tissue, delivering antigens directly to the immune processing centers within the tissue architecture. The crypts are not passive surface area enhancers — they are intake channels.
Three hydrodynamic forces drive this active channeling. The Venturi effect operates at the posterior choanae. As the nasal cavity narrows at this point, flow velocity increases. The adenoid crypts sit immediately downstream of this narrowing, and the accelerated flow passing over the crypt openings creates a negative pressure differential that draws mucus into the crypts — similar to how a river's current pulls water into side channels and eddies.
Capillary action contributes a second force. The narrow dimensions of the adenoid crypts (some measuring less than 1 mm in width) create capillary forces that draw the aqueous mucus layer into the channels, similar to how water is drawn into narrow rock fissures.
The specialized epithelial architecture within the crypts provides the third mechanism. The crypt epithelium is not uniform — it contains patches of reticulated, sponge-like epithelium heavily infiltrated by lymphocytes, macrophages, and dendritic cells. Ogasawara et al. (2011) demonstrated that the lymphoepithelium of human adenoids contains specialized antigen-uptake regions with reduced barrier function that facilitate transepithelial antigen sampling.[16] Perry (1994) described this reticulated epithelium in the palatine tonsil as containing an extensive system of channels occupying nearly the full thickness of the epithelium.[9] M cells (microfold cells) are present within this crypt epithelium and are specialized for transepithelial antigen transport. Fujimura (2000) demonstrated that M cells in the human nasopharyngeal tonsil actively take up antigens via vesicular transport and deliver them to underlying lymphocytes — functionally identical to M cells in Peyer's patches of the gut.[10] Hathaway and Kraehenbuhl (2000) reviewed the broader role of M cells in mucosal immunity, confirming their function as antigen-sampling portals across mucosal surfaces.[11] Alvarez-Arguedas et al. (2025) used single-nucleus RNA sequencing to identify airway M cells in human adenoids that develop from progenitor club cells and express a gene signature distinct from intestinal M cells.[12]
The canyon walls themselves are immunologically active. Pajusto et al. (2005) showed that the base of the adenoid crypt expresses PECAM-1 (CD31) while the orifice expresses VCAM-1, indicating that different regions of the crypt have distinct abilities to recruit leukocytes.[13] The base of the crypt is consistently infiltrated with leukocytes, forming a reticular lymphoepithelial structure — the immune processing center to which the river delivers its antigenic cargo.[13] Forsgren et al. (1995) demonstrated that over 90% of intraepithelial CD3+ T cells in the adenoid crypt are of the CD45RO+ memory phenotype, indicating active, ongoing immune surveillance.[14]
The canyon analogy extends further. Just as slot canyons create unique microenvironments at different depths, the adenoid crypts create distinct immunological microenvironments. The orifice, with its VCAM-1 expression, recruits one population of leukocytes; the base, with its PECAM-1 expression and reticular epithelium, recruits another.[13] The deeper the antigen penetrates into the canyon, the more intimate its contact with the immune processing machinery.
The adenoid is therefore not a passive filter but an active intake system that uses the river's flow dynamics to pull antigen-laden mucus deep into its immune processing architecture. The antigens are not merely touching the surface — they are being delivered into the tissue by the river itself.

5. Waldeyer’s Ring and the First Breath: The Immunological Ignition Event

The nasopharynx-associated lymphoid tissue (NALT), including the adenoids, palatine tonsils, lingual tonsils, and posterior pharyngeal lymphoid aggregates, forms Waldeyer's ring — a 360-degree lymphoid barrier surrounding the pharynx.[7,8,11] This ring is positioned at the exact anatomical point where the mucosal river converges from multiple tributaries (nasal, sinus, eustachian, pulmonary, salivary) before descending into the gastrointestinal tract.
Perry (1994) demonstrated that the reticulated crypt epithelium of the palatine tonsil contains an extensive system of channels occupying nearly the full thickness of the epithelium, infiltrated by lymphocytes, plasma cells, and mononuclear phagocytic cells.[9] Antigens that escape adenoid processing encounter the palatine tonsils laterally, the posterior pharyngeal lymphoid aggregates posteriorly, and the lingual tonsils anteroinferiorly — creating a redundant, 360-degree antigen trap from which the mucosal river cannot pass without immune surveillance.
This architecture has particular significance at birth. Neonates are obligate nasal breathers. The first breath draws environmental air — laden with bacteria, fungi, viruses, allergens, and particulate matter — through the nasal cavity and over the adenoids. Van Kempen et al. (2000) noted that primary lymphoid follicles are present in the adenoids by 16 weeks of gestation, but germinal centers — reflecting active B-cell responses — do not form until shortly after birth.[7]
The first breath, in this framework, represents an immunological ignition event — the sudden exposure of a prepared but quiescent lymphoid system to an overwhelming volume of environmental antigens, triggering the rapid formation of germinal centers and the initiation of adaptive immune responses that will shape the individual's immunological repertoire for life. The mucosal river, initiated by the first ciliary beats in the newborn's nasal cavity, concentrates and funnels these antigens into the canyons of the adenoids, where M cells transport them to the underlying lymphoid tissue for processing.[10,12] Antigens that bypass the adenoids are captured by the downstream components of Waldeyer's ring.
Morris et al. (2016) demonstrated that adenoidal follicular T helper cells provide stronger B-cell help than those from tonsils — with higher CXCR5 and inducible costimulator expression and greater proliferative capacity upon stimulation.[15] This finding suggests the adenoid is the primary immune processing station of Waldeyer's ring, consistent with its position as the first lymphoid tissue encountered by the mucosal river.

6. The River as Immune Conduit

The mucosal liquid layer is not merely a passive barrier but an active transport medium for a diverse array of immune molecules and cells. Secretory IgA (sIgA) — the most abundantly produced immunoglobulin in the human body at approximately 3–5 g/day — is transcytosed across epithelial cells and released into the mucosal liquid layer, where it provides immune exclusion by binding pathogens and preventing their adherence to the epithelium. Brandtzaeg (2003) characterized this sIgA transport as a defining feature of the mucosal immune system.[8] Antimicrobial peptides including defensins (alpha and beta), lysozyme, lactoferrin, and cathelicidin (LL-37) are secreted into the liquid layer by epithelial cells, submucosal glands, and neutrophils.
The liquid layer also transports cytokines, chemokines, and damage-associated molecular patterns (DAMPs) that coordinate local and regional immune responses. Immune cells — including neutrophils, macrophages, dendritic cells, and innate lymphoid cells — migrate through and within the mucosal liquid layer to sites of infection or injury.
The directional flow of the mucosal river — from nose to anus — means that immune products generated in the upper airway are delivered to the pharynx, swallowed, and distributed throughout the gastrointestinal tract. This creates a functional link between upper airway immune surveillance and gut mucosal immunity. Brandtzaeg (2011) described how the tonsillar immune system produces immunocytes bearing the J (joining) chain carbohydrate necessary for binding IgA monomers to one another and to the secretory component — and these immunocytes can migrate to other mucosal sites to exert effector function.[17]

7. Pepsin as a Pathologic Passenger in the River

The mucosal river normally flows in one direction — from nose to anus, driven by mucociliary clearance and peristalsis. Gastroesophageal reflux reverses this flow, propelling gastric contents — including pepsin, the proteolytic enzyme produced exclusively by gastric chief cells — upward through the esophagus into the pharynx and beyond.
Pepsin has been detected in the middle ear fluid of children with otitis media in 15–77% of cases depending on the study. O'Reilly et al. (2008) documented pepsin in middle ear effusions and proposed extraesophageal reflux as a contributing factor in pediatric otitis media.[18] For pepsin to reach the middle ear, it must ascend from the stomach through the esophagus, pharynx, nasopharynx, and eustachian tube — traveling against gravity, against peristalsis, and against mucociliary clearance.
The mucosal river framework offers a mechanism for this seemingly improbable transit. The continuous liquid layer provides a conduit through which refluxate can travel as a thin film along the mucosal surface, potentially facilitated by the same liquid layer that normally transports immune products in the opposite direction. The posterior nasopharynx — where the mucosal river converges — would receive the highest concentration of ascending refluxate, with progressive dilution as the refluxate spreads anteriorly into the nasal cavity.
This directional exposure gradient predicts that reflux-mediated inflammation should be most severe posteriorly and diminish anteriorly. Clinical observations support this prediction. Javorska et al. (2024) found that the mulberry posterior inferior nasal turbinate (MPINT), a distinctive hypertrophic mucosal change, was present in 69% of patients with chronic extraesophageal reflux symptoms, and these patients had significantly more acidic pharyngeal pH drops than those without MPINT.[19] The posterior inferior turbinate — the first nasal structure contacted by ascending refluxate — would be expected to show the most severe changes, consistent with clinical observations that the mulberry appearance is densest posteriorly and thins anteriorly.
Once pepsin reaches extra-esophageal tissues, it causes inflammation through a mechanism independent of acid. Tan et al. (2024) demonstrated that pepsin activates the ROS/NLRP3/IL-1β inflammasome signaling pathway in laryngeal epithelial cells, with pepsin expression positively correlated with ROS, caspase-1, and IL-1β levels in laryngeal tissues.[41] Wang et al. (2019) showed that pepsin, even at neutral pH 7.0, increases the expression of HSP70 in human nasal epithelial cells by activating the JNK/MAPK signaling pathway, with inhibition of JNK1/2 reducing HSP70 expression.[42] Johnston et al. (2006) had earlier demonstrated that receptor-mediated uptake of pepsin by laryngeal epithelial cells depletes the protective stress proteins Sep70 and Sep53, altering the normal acid-mediated stress protein response and potentially contributing to cellular injury.[43] These findings explain why proton pump inhibitor therapy often fails to resolve extraesophageal reflux symptoms — the damage is pepsin-mediated, not acid-mediated.
The mucosal river framework reframes pepsin not as a localized irritant but as a pathologic passenger in the river — one that travels the same conduit as immune molecules but in the opposite direction, causing inflammation at every mucosal surface it contacts along the way.

8. Disruption of the Mucosal Liquid Layer by Inhaled Toxicants

Cigarette smoke provides a real-world demonstration of what happens when the mucosal river is disrupted at the molecular level. The primary mechanism is acquired dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR), the chloride channel that drives fluid secretion onto airway surfaces.
Cigarette smoke causes rapid internalization of CFTR from the apical membrane via clathrin/dynamin-dependent endocytosis, followed by retrograde trafficking to the endoplasmic reticulum — a pathway not previously reported for mammalian ion channels. Marklew et al. (2019) characterized this novel retrograde trafficking mechanism in detail.[38] This process is mediated in part by acrolein, a volatile aldehyde in cigarette smoke that blocks CFTR channel gating and is present at elevated levels in the plasma of smokers — meaning the CFTR dysfunction is systemic, not limited to directly smoke-exposed tissues. Raju et al. (2013) demonstrated that smokers have elevated sweat chloride levels (29.45 vs. 14.5 mEq in controls) and 65% reduced intestinal CFTR function, confirming that smoking causes CFTR dysfunction in organs never directly exposed to smoke.[20] Cantin et al. (2006) independently confirmed acquired CFTR deficiency in the nasal respiratory epithelium of cigarette smokers using nasal potential difference measurements, with smokers showing a blunted response to chloride-free buffer and isoproterenol compared with nonsmokers (-9.6 ± 4.0 vs. -22.3 ± 10.1 mV; p < 0.001).[21] Mall et al. (2023) confirmed that CFTR impairment has been demonstrated in the upper and lower airways, sweat glands, and intestines of smokers, suggesting both pulmonary and systemic defects.[22]
Smoke also inactivates SPLUNC1, a secreted protein that normally inhibits ENaC (the epithelial sodium channel). When SPLUNC1 is destroyed, ENaC hyperabsorbs sodium and water from the airway surface, further dehydrating the mucus layer.
The result is functionally identical to cystic fibrosis: mucus hyperconcentration, increased viscosity, impaired mucociliary clearance, and formation of adherent mucus plaques that create hypoxic niches for bacterial colonization. Boucher (2019) demonstrated that relatively small changes in mucus hydration — from 98% water (2% solids) to 92% water (8% solids) — transform mucus from a freely flowing gel into an adherent, stasis-producing plaque that compresses cilia and produces mucus stasis and adhesion.[6] Hill et al. (2022) provided the comprehensive biophysical framework for this transition, showing that mucus transport rates are accurately predicted by the gel-on-brush model from the relative osmotic moduli of the mucus and periciliary-glycocalyceal layers.[23]
In the nasal and sinus epithelium specifically, Han et al. (2023) demonstrated acquired CFTR dysfunction in children with chronic rhinosinusitis — reduced ionocyte numbers, decreased CFTR function, and ionocytes that lost CFTR expression entirely.[24] Christensen et al. (2018) conducted a systematic review of 112 articles and confirmed a strong correlation between active and passive cigarette smoke exposure and CRS prevalence, with mechanistic studies showing alterations in chloride ion transport, reduced mucociliary clearance, and reduced ciliary generation in sinonasal epithelia.[25] Hutson et al. (2021) found a dose-dependent association, with a 1.5% increase in CRS prevalence for each year smoked.[26]
Waterpipe (hookah) smoking is instructive. Despite passing through water — which humidifies the smoke — waterpipe smoke causes similar or greater epithelial damage. Strulovici-Barel et al. (2016) demonstrated pulmonary abnormalities in young, light-use waterpipe smokers including airway basal cell hyperplasia and disordered differentiation.[27] This demonstrates that the river's disruption is not caused by drying of the air but by destruction of the cellular pumps that generate the liquid layer. The river depends on active ion transport, not passive humidity.
Within the mucosal river framework, smoking dams the river at the molecular level: Cigarette Smoke → Acrolein (systemic) → CFTR internalization in epithelium → Reduced Cl⁻ secretion → Reduced ASL hydration → Mucus hyperconcentration → Ciliary compression → Mucociliary stasis → Bacterial colonization/biofilm → Chronic inflammation. This cascade affects the entire continuous mucosal system simultaneously — from sinuses to colon — because the CFTR dysfunction is systemic.

9. The Dehydration Hypothesis

If the mucosal river's integrity depends on active fluid secretion by epithelial cells, then systemic dehydration — which reduces the body's available water for transepithelial secretion — should impair the river's flow, composition, and protective function.
Several lines of evidence support this hypothesis. Boucher (2019) demonstrated that relatively small changes in mucus hydration produce disease — the transition from 2% solids to 8% solids is sufficient to compress cilia and produce mucus stasis.[6] Marshall et al. (2021) showed that mild systemic dehydration (2.5–2.7% body weight loss) measurably impairs pulmonary function, with reductions in forced vital capacity (152 ± 143 mL) and increases in residual volume (216 ± 177 mL). Only systemic (oral) rehydration reversed these changes — not nebulized isotonic saline.[28] This confirms that the airway surface liquid layer is dependent on systemic hydration, not local humidity.
In the gut, Fan et al. (2025) demonstrated that water deprivation in a murine model causes colon shortening, villus atrophy, goblet cell loss, and barrier disruption correlated with water-deprivation severity; oral supplementation of Bacteroides acidifaciens restored colonic architecture, enhanced mucin secretion, and ameliorated barrier dysfunction.[29] Roca Rubio et al. (2021) showed that sauna-induced dehydration (3% body weight loss) increases gastroduodenal and small intestinal permeability in healthy humans, with elevated lipopolysaccharide-binding protein (LBP), IL-6, and IL-8 — markers of bacterial translocation — without substantial enterocyte damage.[30] Tropini et al. (2018) demonstrated that osmotic perturbation of the gut causes reproducible extinction of abundant commensal taxa, expansion of Proteobacteria, decimation of the mucus barrier, and lasting IgG responses against commensal bacteria.[31]
In the upper airway, Fortes et al. (2012) showed that exercise-induced dehydration (approximately 3% body weight loss) significantly decreased saliva flow rate (67% reduction at 3% body mass loss), alpha-amylase secretion rate (44% reduction), and lysozyme secretion rate (46% reduction) — key antimicrobial proteins in the mucosal liquid layer. All saliva variables returned to baseline upon rehydration.[32]
Systemic dehydration disrupts the mucosal river through a cascade: reduced transepithelial fluid secretion → mucus hyperconcentration → ciliary compression → mucociliary stasis → impaired immune transport → bacterial overgrowth → chronic inflammation. This cascade would affect the entire continuous mucosal system — from sinuses to colon — simultaneously, which may explain the clinical observation that patients with chronic sinusitis frequently have comorbid gastrointestinal complaints.

10. The Antibiotic-Dehydration Double Hit

Antibiotics and dehydration may act synergistically to disrupt the mucosal river. Antibiotics eliminate commensal bacteria that help maintain mucus barrier integrity. Krigul et al. (2024) demonstrated that a history of repeated antibiotic usage leads to microbiota-dependent mucus defects — reduced mucus growth rate and increased mucus penetrability — with known mucus-utilizing bacteria including Akkermansia muciniphila and Bacteroides fragilis dominating in the antibiotic-shaped gut.[33] Sawaed et al. (2024) showed that antibiotics damage the colonic mucus barrier in a microbiota-independent manner, inducing endoplasmic reticulum stress that inhibits colonic mucus secretion, leading to bacterial penetrance into the mucus layer and translocation of microbial antigens into circulation.[34] Simultaneously, dehydration reduces the water content of the remaining mucus, increasing its viscosity and impairing clearance.
The bystander effect of antibiotics on commensal organisms is substantial. Holmes et al. (2016) described how over 80% of antibiotic selective pressure occurs as bystander selection — the antibiotic acts on commensal organisms that were never the target of treatment, reshaping microbial ecology across every mucosal surface.[39] De Nies et al. (2023) reviewed how antibiotics administered to target a specific pathogen cause collateral damage to the patient's resident microbial population, suppressing commensal species that provide colonization resistance against foreign pathogens and leading to increased risk of subsequent infection.[35] Maier et al. (2021) characterized the activity spectra of 144 antibiotics on 38 representative human gut microbiome species, finding that macrolides and tetracyclines inhibited nearly all commensals tested and killed several species — with killed bacteria more readily eliminated from communities than those merely inhibited.[36] Duan et al. (2022) reviewed how antibiotic-induced changes in gut microbiota composition weaken the gut barrier through changes in mucin, cytokine, and antimicrobial peptide production by intestinal epithelial cells.[37]
When a dehydrated patient receives an unnecessary antibiotic, two disruptions occur simultaneously: (1) the liquid layer is already thinned and viscous from dehydration, impairing mucociliary clearance and immune transport; and (2) the antibiotic eliminates commensal bacteria that help maintain the mucus barrier, further compromising the river's integrity. The combined effect may be greater than either insult alone — a "double hit" that transforms a self-limited viral infection into a secondary bacterial infection, paradoxically justifying the antibiotic that was unnecessary in the first place.
This double-hit hypothesis generates a testable prediction: patients who are systemically dehydrated at the time of antibiotic administration should have higher rates of secondary infection, antibiotic-associated adverse events, and Clostridioides difficile infection than euhydrated patients receiving the same antibiotic. This prediction has not been tested.

11. Clinical Implications and Testable Predictions

The mucosal river framework generates several testable predictions:
(a) Pepsin gradient: If pepsin ascends the mucosal river from the stomach, its concentration should decrease with distance from the nasopharynx. Mucosal lavage samples from the posterior nasopharynx, middle meatus, anterior nasal cavity, and frontal recess should show a posterior-to-anterior concentration gradient in patients with documented extraesophageal reflux.
(b) Posterior turbinate predominance: If reflux-mediated inflammation follows the river's path, the posterior inferior turbinate should show greater mucosal hypertrophy, inflammatory cell infiltration, and pepsin immunohistochemical staining than the anterior turbinate in patients with extraesophageal reflux — but not in patients with allergic rhinitis or controls.
(c) Dehydration-microbiome interaction: Controlled dehydration (e.g., 3% body weight loss via sauna, per the Roca Rubio et al. protocol) should produce measurable changes in nasal and oropharyngeal microbiome composition, mucociliary clearance time, and salivary antimicrobial protein concentrations — all reversible with oral rehydration.[30]
(d) Antibiotic-dehydration synergy: Patients who are dehydrated at the time of antibiotic administration should have worse outcomes (higher secondary infection rates, more adverse events) than euhydrated patients receiving the same antibiotic.
(e) First-breath immunology: Neonatal adenoid tissue sampled within hours of birth should show rapid germinal center formation and B-cell activation compared to fetal adenoid tissue, with the rate of activation correlating with the microbial diversity of the delivery environment (vaginal delivery vs. cesarean section, home vs. hospital).

12. The PSS Connection

The Posterior Sinonasal Syndrome (PSS) — a clinical entity characterized by posterior-predominant sinonasal symptoms in the setting of extraesophageal reflux — represents the clinical manifestation of the mucosal river framework applied to pepsin-mediated disease. The Pepsin Symptom Score (PSS), a symptom-based screening tool for pepsin-mediated sinonasal disease, identifies patients in whom the river is carrying a pathologic passenger (pepsin) that causes inflammation preferentially at the posterior confluence where the river converges.
The mucosal river framework provides the mechanistic rationale for why PSS exists as a clinical entity: the posterior nasopharynx is the anatomical point where ascending refluxate meets the converging mucosal river, creating the highest concentration of pepsin exposure. The framework also explains why PSS symptoms are posterior-predominant and why they may progress anteriorly over time — as the river carries pepsin forward from its point of entry.

13. Conclusions

The continuous mucosal liquid layer — from the anterior nares to the anus — represents a unified physiological system that has been studied in regional isolation but never conceptualized as a whole. The mucosal river framework proposed here integrates pulmonary, rhinological, gastroenterological, and immunological evidence into a single model that explains how immune surveillance is coordinated across the entire aerodigestive tract, how pathologic agents like pepsin can travel against the river's flow to cause disease at distant sites, and how disruption of the river — by dehydration, inhaled toxicants, or antibiotics — can produce simultaneous disease across multiple organ systems.
The adenoid canyons, with their M-cell-lined walls and hydrodynamic antigen delivery system, represent the river's primary immune processing station — and the first breath represents the moment the river begins to flow, igniting the adaptive immune system. The framework generates multiple testable predictions and provides a unifying mechanism for clinical observations that have previously been explained in isolation.
The river flows from the first breath to the last. Understanding its dynamics may reshape how we approach chronic inflammatory diseases of the airway and digestive tract.

Funding

No external funding was received.

Conflicts of Interest

The author declares no conflicts of interest.

AI Disclosure

During the preparation of this manuscript the author used Claude (Anthropic) and OpenEvidence to assist with literature identification, structural organization, and editorial refinement. The author reviewed and edited all content and takes full responsibility for all content.

References

  1. Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9(4):a028241.
  2. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233-2247.
  3. Johansson MEV, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10(6):352-361.
  4. Pelaseyed T, Bergstrom JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8-20.
  5. Schilder AGM, Chonmaitree T, Cripps AW, et al. Otitis media. Nat Rev Dis Primers. 2016;2:16063.
  6. Boucher RC. Muco-obstructive lung diseases. N Engl J Med. 2019;380(20):1941-1953.
  7. van Kempen MJ, Rijkers GT, Van Cauwenberge PB. The immune response in adenoids and tonsils. Int Arch Allergy Immunol. 2000;122(1):8-19.
  8. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol. 2003;67 Suppl 1:S69-S76.
  9. Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat. 1994;185(Pt 1):111-127.
  10. Fujimura Y. Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans. Virchows Arch. 2000;436(6):560-566.
  11. Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol Life Sci. 2000;57(2):323-332.
  12. Alvarez-Arguedas S, Mazhar K, Wangzhou A, et al. Single cell transcriptional analysis of human adenoids identifies molecular features of airway microfold cells. Mucosal Immunol. 2025;S1933-0219(25)00077-7.
  13. Pajusto M, Tarkkanen J, Mattila PS. Platelet endothelial cell adhesion molecule-1 is expressed in adenoidal crypt epithelial cells. Scand J Immunol. 2005;61(1):82-86.
  14. Forsgren J, Rynnel-Dagoo B, Christensson B. In situ analysis of the immune microenvironment of the adenoid in children with and without secretory otitis media. Ann Otol Rhinol Laryngol. 1995;104(3):189-196.
  15. Morris MC, Kozara K, Salamone F, Benoit M, Pichichero ME. Adenoidal follicular T helper cells provide stronger B-cell help than those from tonsils. Laryngoscope. 2016;126(2):E80-E85.
  16. Ogasawara N, Kojima T, Go M, et al. Epithelial barrier and antigen uptake in lymphoepithelium of human adenoids. Acta Otolaryngol. 2011;131(2):116-123.
  17. Brandtzaeg P. Immune functions of nasopharyngeal lymphoid tissue. Adv Otorhinolaryngol. 2011;72:20-24.
  18. O'Reilly RC, He Z, Bloedon E, et al. The role of extraesophageal reflux in otitis media in infants and children. Laryngoscope. 2008;118(7 Pt 2 Suppl 116):1-9.
  19. Javorska K, Zelenik K, Formanek M, et al. Mulberry posterior inferior nasal turbinate as a sign of extraesophageal reflux. Eur Arch Otorhinolaryngol. 2024;281(5):2505-2512.
  20. Raju SV, Jackson PL, Courville CA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188(11):1321-1330.
  21. Cantin AM, Hanrahan JW, Bilodeau G, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006;173(10):1139-1144.
  22. Mall MA, Criner GJ, Miravitlles M, et al. Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond. Eur Respir J. 2023;61(4):2201307.
  23. Hill DB, Button B, Rubinstein M, Boucher RC. Physiology and pathophysiology of human airway mucus. Physiol Rev. 2022;102(4):1757-1836.
  24. Han X, Bhatt JM, Goss CH, et al. Acquired CFTR dysfunction in pediatric chronic rhinosinusitis. Laryngoscope. 2023;133(12):3340-3348.
  25. Christensen DN, Franks ZG, McCrary HC, Saleh AA, Chang EH. A systematic review of the association between cigarette smoke exposure and chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2018;158(5):801-816.
  26. Hutson K, Clark A, Hopkins C, et al. Evaluation of smoking as a modifying factor in chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2021;147(2):159-165.
  27. Strulovici-Barel Y, Shaykhiev R, Engel T, et al. Pulmonary abnormalities in young, light-use waterpipe (hookah) smokers. Am J Respir Crit Care Med. 2016;194(5):587-595.
  28. Marshall H, Gibson OR, Romer LM, et al. Systemic but not local rehydration restores dehydration-induced changes in pulmonary function in healthy adults. J Appl Physiol. 2021;130(3):517-527.
  29. Fan S, Cai X, Cui W, et al. Restoration of gut integrity by Bacteroides acidifaciens in water-deprived conditions. Biochem Biophys Res Commun. 2025;767:151917.
  30. Roca Rubio MF, Eriksson U, Brummer RJ, Konig J. Sauna dehydration as a new physiological challenge model for intestinal barrier function. Sci Rep. 2021;11(1):15514.
  31. Tropini C, Moss EL, Merrill BD, et al. Transient osmotic perturbation causes long-term alteration to the gut microbiota. Cell. 2018;173(7):1742-1754.e17.
  32. Fortes MB, Diment BC, Di Felice U, Walsh NP. Dehydration decreases saliva antimicrobial proteins important for mucosal immunity. Appl Physiol Nutr Metab. 2012;37(5):850-859.
  33. Krigul KL, Feeney RH, Wongkuna S, et al. A history of repeated antibiotic usage leads to microbiota-dependent mucus defects. Gut Microbes. 2024;16(1):2377570.
  34. Sawaed J, Zelik L, Levin Y, et al. Antibiotics damage the colonic mucus barrier in a microbiota-independent manner. Sci Adv. 2024;10(37):eadp4119.
  35. de Nies L, Kobras CM, Stracy M. Antibiotic-induced collateral damage to the microbiota and associated infections. Nat Rev Microbiol. 2023;21(12):789-804.
  36. Maier L, Goemans CV, Wirbel J, et al. Unravelling the collateral damage of antibiotics on gut bacteria. Nature. 2021;599(7883):120-124.
  37. Duan H, Yu L, Tian F, et al. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr. 2022;62(6):1427-1452.
  38. Marklew AJ, Patel W, Moore PJ, et al. Cigarette smoke exposure induces retrograde trafficking of CFTR to the endoplasmic reticulum. Sci Rep. 2019;9(1):13655.
  39. Holmes AH, Moore LSP, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176-187.
  40. Gustafsson JK, Johansson MEV. The role of goblet cells and mucus in intestinal homeostasis. Nat Rev Gastroenterol Hepatol. 2022;19(12):785-803.
  41. Tan JJ, Dai YF, Wang F, et al. Pepsin-mediated inflammation in laryngopharyngeal reflux via the ROS/NLRP3/IL-1β signaling pathway. Cytokine. 2024;178:156568.
  42. Wang J, Zhao Y, Ren J, et al. Heat shock protein 70 is induced by pepsin via MAPK signaling in human nasal epithelial cells. Eur Arch Otorhinolaryngol. 2019;276(3):767-774.
  43. Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol. 2006;115(1):47-58.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2026 MDPI (Basel, Switzerland) unless otherwise stated

Accessibility

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings